Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

[1]  A. Levy.  Modification of HDL structure and function in individuals with diabetes and the haptoglobin 2-2 genotype , 2009 .

[2]  D. Sviridov,et al.  Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque , 2008, Circulation research.

[3]  D. Sviridov,et al.  High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[4]  A. Levy,et al.  Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype , 2008, Diabetes.

[5]  J. Kastelein,et al.  Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus , 2008, Diabetologia.

[6]  S. Reddy,et al.  D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet Published, JLR Papers in Press, October 9, 2007. , 2008, Journal of Lipid Research.

[7]  S. Reddy,et al.  Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits Published, JLR Papers in Press, August 10, 2007. , 2007, Journal of Lipid Research.

[8]  L. Jonasson,et al.  Neutrophil Activation Status in Stable Coronary Artery Disease , 2007, PloS one.

[9]  K. Pritchard,et al.  Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[10]  Y. Naito,et al.  Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. , 2007, Atherosclerosis.

[11]  D. Sviridov,et al.  Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties , 2007, Diabetologia.

[12]  Colin Berry,et al.  Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. , 2007, JAMA.

[13]  A. Campa,et al.  Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes , 2006, Clinical and experimental immunology.

[14]  L. Ignarro,et al.  D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet Published, JLR Papers in Press, July 12, 2006. , 2006, Journal of Lipid Research.

[15]  A. Dart,et al.  Raised Plasma Soluble P-Selectin in Peripheral Arterial Occlusive Disease Enhances Leukocyte Adhesion , 2005, Circulation research.

[16]  T. McDonald,et al.  Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. , 2005, Diabetes.

[17]  P. Barter,et al.  Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits , 2005, Circulation.

[18]  D. Gordon,et al.  High-Density Lipoprotein Cholesterol and Cardiovascular Disease , 2005 .

[19]  Imran Awan,et al.  Leukocyte count and coronary heart disease: implications for risk assessment. , 2004, Journal of the American College of Cardiology.

[20]  P. Barter,et al.  Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[22]  M. Hayden,et al.  Restoration of Endothelial Function by Increasing High‐Density Lipoprotein in Subjects With Isolated Low High‐Density Lipoprotein , 2003, Circulation.

[23]  Kazuo Haze,et al.  Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes , 2002, Circulation.

[24]  P. Barter,et al.  Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells , 2002, Current opinion in lipidology.

[25]  F. Ruschitzka,et al.  High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.

[26]  A. Catania,et al.  Polymorphonuclear leukocyte integrin profile in diabetes mellitus. , 2002, Clinical hemorheology and microcirculation.

[27]  M. Diamond,et al.  ICAM-1 ( CD 54 ) : A Counter-Receptor for Mac-1 ( CDllb / CD 18 ) , 2002 .

[28]  J. Ramires,et al.  Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia. , 2001, Atherosclerosis.

[29]  L. Lindbom,et al.  Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  J. Gamble,et al.  Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. , 2000, Journal of lipid research.

[31]  P. Lerch,et al.  Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans. , 1999, Arteriosclerosis, Thrombosis and Vascular Biology.

[32]  P. Barter,et al.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II. , 1999, The Biochemical journal.

[33]  J. Gamble,et al.  Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. , 1999, Journal of lipid research.

[34]  J. Gamble,et al.  Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[35]  W. Erl,et al.  HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. , 1997, Journal of the American College of Cardiology.

[36]  S. de Servi,et al.  Increased expression of CD11b/CD18 on phagocytes in ischaemic disease: a bridge between inflammation and coagulation , 1997, European journal of clinical investigation.

[37]  D. Hatchell,et al.  Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. , 1997, The American journal of the medical sciences.

[38]  J. E. Doran,et al.  Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia , 1996, The Journal of experimental medicine.

[39]  P. Lerch,et al.  Production and Characterization ofa Reconstituted High Density Lipoprotein for Therapeutic Applications , 1996, Vox sanguinis.

[40]  F. Berthezène,et al.  Non-insulin dependent diabetes and reverse cholesterol transport. , 1996, Atherosclerosis.

[41]  J. Gamble,et al.  High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[42]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[43]  J. Taylor,et al.  Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Diamond,et al.  A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen , 1993, The Journal of cell biology.

[45]  R. Krauss,et al.  Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. , 1992, Journal of lipid research.

[46]  M. Miller,et al.  Long‐term Predictors of Subsequent Cardiovascular Events With Coronary Artery Disease and ‘Desirable’ Levels of Plasma Total Cholesterol , 1992, Circulation.

[47]  T. Forte,et al.  Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. , 1992, Biochimica et biophysica acta.

[48]  M. Diamond,et al.  ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18) , 1990, The Journal of cell biology.

[49]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[50]  P. Barter,et al.  Evidence in vitro that hepatic lipase reduces the concentration of apolipoprotein A-I in rabbit high-density lipoproteins. , 1990, Biochimica et biophysica acta.

[51]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[52]  C. Fielding,et al.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.

[53]  N. Miller.  High-density lipoprotein: a major risk factor for coronary atherosclerosis. , 1987, Bailliere's clinical endocrinology and metabolism.

[54]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[55]  M. Takayama,et al.  A new enzymatic method for determination of serum choline-containing phospholipids. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[56]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[57]  P. Röschlau,et al.  [A practical enzymatic cholesterol determination]. , 1977, Das Medizinische Laboratorium.

[58]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[59]  A. Wahlefeld.  Triglycerides Determination after Enzymatic Hydrolysis , 1974 .

[60]  F. Hatch.  Practical methods for plasma lipoprotein analysis. , 1968, Advances in lipid research.

[61]  H. Bergmeyer.  Methods of Enzymatic Analysis , 2019 .